Fujian Cosunter Pharmaceutical Co., Ltd. — Investor Relations & Filings
Fujian Cosunter Pharmaceutical Co., Ltd. specializes in the research, development, production, and commercialization of pharmaceutical products. The company maintains a strong focus on antiviral therapies, particularly for the treatment of chronic Hepatitis B, with a product portfolio featuring Entecavir, Tenofovir Disoproxil Fumarate, and Adefovir Dipivoxil. Its therapeutic reach extends to cardiovascular, respiratory, and digestive system medications. The organization operates integrated manufacturing platforms and research centers dedicated to the innovation of small molecule drugs and high-end generic formulations. By leveraging advanced chemical synthesis and formulation technologies, the company delivers a diverse range of therapeutic solutions aimed at addressing unmet medical needs and improving patient health outcomes.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于修订《公司章程》、制定及修订公司部分管理制度的公告 | 2025-10-29 | Chinese | |
| 会计师事务所选聘制度（2025年10月） | 2025-10-29 | Chinese | |
| 董事、高级管理人员离职管理制度（2025年10月） | 2025-10-29 | Chinese | |
| 2025年三季度报告 | 2025-10-29 | Chinese | |
| 关于第五届监事会第十次会议决议的公告 | 2025-10-29 | Chinese | |
| 关于控股子公司股权转让及增资扩股完成工商变更并取得营业执照的公告 | 2025-10-22 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 37345266 | 关于修订《公司章程》、制定及修订公司部分管理制度的公告 | 2025-10-29 | Chinese | ||
| 37345262 | 会计师事务所选聘制度（2025年10月） | 2025-10-29 | Chinese | ||
| 37345259 | 董事、高级管理人员离职管理制度（2025年10月） | 2025-10-29 | Chinese | ||
| 37345257 | 2025年三季度报告 | 2025-10-29 | Chinese | ||
| 37345254 | 关于第五届监事会第十次会议决议的公告 | 2025-10-29 | Chinese | ||
| 37345251 | 关于控股子公司股权转让及增资扩股完成工商变更并取得营业执照的公告 | 2025-10-22 | Chinese | ||
| 37345250 | 关于乙肝治疗一类创新药GST-HG131研究成果被美国肝病研究协会接受为年会最新突破摘要报告的公告 | 2025-10-10 | Chinese | ||
| 37345248 | 关于第五届董事会第十二次会议决议的公告 | 2025-09-24 | Chinese | ||
| 37345246 | 关于控股子公司签订A轮增资协议之补充协议（二）暨承诺履行期限延长的公告 | 2025-09-24 | Chinese | ||
| 37345233 | 关于控股子公司股权转让及增资扩股暨公司放弃优先权的进展公告 | 2025-09-24 | Chinese | ||
| 37345229 | 关于2025年第二次临时股东大会决议的公告 | 2025-09-17 | Chinese | ||
| 37345226 | 国浩律师（上海）事务所关于福建广生堂药业股份有限公司2025年第二次临时股东大会法律意见书 | 2025-09-17 | Chinese | ||
| 37345224 | 国联民生证券承销保荐有限公司关于福建广生堂药业股份有限公司2025年度向特定对象发行A股股票之发行保荐书 | 2025-09-08 | Chinese | ||
| 37345218 | 国浩律师（上海）事务所关于福建广生堂药业股份有限公司2025年度向特定对象发行A股股票之补充法律意见书（三） | 2025-09-08 | Chinese | ||
| 37345210 | 关于福建广生堂药业股份有限公司申请向特定对象发行股票的审核问询函的回复 | 2025-09-08 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Fujian Cosunter Pharmaceutical Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55423/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55423 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55423 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55423 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55423}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Fujian Cosunter Pharmaceutical Co., Ltd. (id: 55423)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.